SCHEMBL7025947

SCHEMBL7025947

CCOC(=O)c1cccc(OC(F)F)c1S(=O)(=O)Cl

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 4/20 0.41
HSD17B10 Q99714 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 2/20 0.40
CDC25B P30305 1/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 4/20 0.39
KDM4E B2RXH2 1/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7034914 0.90 ALDH1A1 (0.49) TSHRSMN1; SMN2ALDH1A1HSD17B10POLB
SCHEMBL7027360 0.87 TSHR (0.46) TSHRSMN1; SMN2ALDH1A1HSD17B10POLB
SCHEMBL7026606 0.85 L3MBTL1 (0.43) TSHRSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL7030663 0.84 TSHR (0.51) TSHRSMN1; SMN2ALDH1A1HSD17B10POLB
SCHEMBL7026481 0.83 NPC1 (0.44) SMN1; SMN2ALDH1A1POLBLMNAKDM4E
SCHEMBL7029826 0.82 TSHR (0.41) TSHRSMN1; SMN2ALDH1A1HSD17B10POLB
SCHEMBL7031800 0.82 TSHR (0.46) TSHRALDH1A1HSD17B10POLBKMT2A
SCHEMBL22979125 0.81 TSHR (0.62) TSHRSMN1; SMN2ALDH1A1HSD17B10POLB
SCHEMBL7029743 0.80 TSHR (0.53) TSHRSMN1; SMN2ALDH1A1HSD17B10POLB
SCHEMBL7032629 0.79 TSHR (0.56) TSHRSMN1; SMN2ALDH1A1HSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162979-A1 Substituted sulphonylamino(thio)carbonyl compounds MULLER KLAUS-HELMUT (DE) 2003-08-28 US disclosed
US-6441195-B1 2-ALKOXYCARBONYL-3-SULPHONAMIDE, SULPHONYL ISOCYANATE OR SULPHONYL ISOTHIOCYANATE-THIOPHENES; PRE- OR POSTEMERGENCE HERBICIDES; EFFICIENCY BAYER AKTIENGESELLSCHAFT (DE) 2002-08-27 US disclosed
US-6180567-B1 REACTING 2-ALKOXYCARBONYL-BENZENESULFONAMIDE DERIVATIVE WITH 1,2,4-(1H)TRIAZOLE-5-(THI)ONE DERIVATIVE BAYER AKTIENGESELLSCHAFT (DE) 2001-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162979-A1 Substituted sulphonylamino(thio)carbonyl compounds CBR3, CTH, CBR1 TSHR 820/4885SMN1; SMN2 2849/4885ALDH1A1 261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.